BUGLIONE DI MONALE E BASTIA, Michela
 Distribuzione geografica
Continente #
NA - Nord America 8.934
EU - Europa 3.503
AS - Asia 1.521
AF - Africa 15
Continente sconosciuto - Info sul continente non disponibili 14
SA - Sud America 11
OC - Oceania 10
Totale 14.008
Nazione #
US - Stati Uniti d'America 8.909
CN - Cina 1.020
UA - Ucraina 979
DE - Germania 599
PL - Polonia 560
IT - Italia 484
HK - Hong Kong 331
FI - Finlandia 254
IE - Irlanda 181
GB - Regno Unito 175
FR - Francia 130
VN - Vietnam 52
IN - India 44
RU - Federazione Russa 43
BE - Belgio 42
SE - Svezia 28
TR - Turchia 27
CA - Canada 23
EU - Europa 14
SG - Singapore 12
AU - Australia 10
BR - Brasile 8
IR - Iran 8
GR - Grecia 6
ID - Indonesia 6
NL - Olanda 6
JP - Giappone 4
EG - Egitto 3
MA - Marocco 3
MU - Mauritius 3
TN - Tunisia 3
AR - Argentina 2
BD - Bangladesh 2
CH - Svizzera 2
IL - Israele 2
KR - Corea 2
SK - Slovacchia (Repubblica Slovacca) 2
SL - Sierra Leone 2
SV - El Salvador 2
TH - Thailandia 2
TW - Taiwan 2
AM - Armenia 1
AT - Austria 1
BG - Bulgaria 1
BY - Bielorussia 1
CZ - Repubblica Ceca 1
EC - Ecuador 1
EE - Estonia 1
ES - Italia 1
HU - Ungheria 1
IS - Islanda 1
KH - Cambogia 1
KW - Kuwait 1
LA - Repubblica Popolare Democratica del Laos 1
MD - Moldavia 1
MY - Malesia 1
NO - Norvegia 1
PK - Pakistan 1
PT - Portogallo 1
SA - Arabia Saudita 1
SI - Slovenia 1
ZA - Sudafrica 1
Totale 14.008
Città #
Fairfield 1.304
Woodbridge 1.085
Ashburn 785
Jacksonville 724
Houston 678
Seattle 562
Warsaw 560
Cambridge 538
Chandler 535
Ann Arbor 495
Wilmington 470
Princeton 337
Hong Kong 328
New York 247
Nanjing 211
Beijing 183
Dublin 181
Dearborn 178
Helsinki 153
Brescia 87
Nanchang 87
San Diego 71
Des Moines 70
Shanghai 55
Changsha 54
Milan 54
Dong Ket 52
Shenyang 50
Hebei 49
Jinan 47
Washington 43
Brussels 42
Tianjin 38
Jiaxing 36
Kunming 34
London 28
Hangzhou 25
San Francisco 23
Lancaster 22
Ningbo 21
Kocaeli 18
Boardman 17
Zhengzhou 17
Ceto 16
Toronto 16
Haikou 15
Nürnberg 15
Taizhou 15
Verona 15
Norwalk 13
Hanover 12
Redwood City 12
Rome 12
Guangzhou 11
Lanzhou 11
Orange 10
Pune 10
Changchun 9
Dresden 8
Iseo 8
Kilburn 8
San Mateo 8
Vignate 8
Hefei 7
New Bedfont 7
Athens 6
Cazzago San Martino 5
Chiswick 5
Hounslow 5
Leawood 5
Monza 5
North York 5
Phoenix 5
Singapore 5
Ardabil 4
Augusta 4
Chongqing 4
Cremona 4
Delhi 4
Falls Church 4
Fuzhou 4
Gunzenhausen 4
Melbourne 4
Sydney 4
Taiyuan 4
Treviglio 4
Westminster 4
Albano Laziale 3
Amsterdam 3
Bologna 3
Castiglione Delle Stiviere 3
Chengdu 3
Chicago 3
Florence 3
Frankfurt am Main 3
Indiana 3
Lappeenranta 3
Orzivecchi 3
Prescot 3
Reggio Emilia 3
Totale 10.977
Nome #
Correlation between Human Papillomavirus Status and Quantitative MR Imaging Parameters including Diffusion-Weighted Imaging and Texture Features in Oropharyngeal Carcinoma 213
Low dose rate brachytherapy (LDR-BT) as monotherapy for early stage prostate cancer in Italy: practice and outcome analysis in a series of 2237 patients from 11 institutions 206
Disease-specific and general health-related quality of life in newly diagnosed prostate cancer patients: the Pros-IT CNR study 200
Overexpression of sialidase NEU3 increases the cellular radioresistance potential of U87MG glioblastoma cells 192
Light and shadows of a new technique: Isphoton total-skin irradiation using helical IMRT feasible, less complex and as toxic as the electrons one? 172
Efficacy of stereotactic body radiotherapy in oligorecurrent and in oligoprogressive prostate cancer: new evidence from a multicentric study 155
Resected pN1 non-small cell lung cancer: recurrence patterns and nodal risk factors may suggest selection criteria for post-operative radiotherapy 150
Pros-IT CNR: an Italian prostate cancer monitoring project 145
Reirradiation in head and neck recurrent or second primary tumor: efficacy, safety, and prognostic factors 142
In reply to Borras et al. the strengthening of Radiation Oncologist role inside multidisciplinary arena within 2025 142
EGFR amplified and overexpressing glioblastomas and association with better response to adjuvant metronomic temozolomide 139
Post-surgical therapeutic approaches to glioblastoma patients submitted to biopsy (BA) or "partial" resection (PR): the possibilities to treat also them without renunciations. Study from the Brescia Neuro-Oncology Group 139
Oral toxicity management in head and neck cancer patients treated with chemotherapy and radiation: Dental pathologies and osteoradionecrosis (Part 1) literature review and consensus statement 138
Radiotherapy in patients with HIV: current issues and review of the literature 138
Cetuximab and Radiotherapy Versus Cisplatin and Radiotherapy for Locally Advanced Head and Neck Cancer: A Randomized Phase II Trial 137
The treatment of patients with 1-3 brain metastases: is there a place for whole brain radiotherapy alone, yet? A retrospective analysis 136
Salvage therapy of small volume prostate cancer nodal failures: A review of the literature 134
THE ROLE OF PRIMARY SURGERY AND EXTERNAL BEAM RADIATION THERAPY IN THE MANAGEMENT OF NON-METASTATIC DUCTAL PROSTATE CANCER: 20-YEAR OUTCOMES FROM A SINGLE INSTITUTION EXPERIENCE 131
A neuro-oncologic challenge: the case of a large, aggressive, malignant meningioma of the skull base with paranasal sinus involvement 131
Reply to 'Comment on 'Efficacy of stereotactic body radiotherapy in oligorecurrent and in oligoprogressive prostate cancer: new evidence from a multicentric study'' 129
Clinical outcomes and toxicity after exclusive versus postoperative radiotherapy in supraglottic cancer: new solutions for old problems? The case of stage I and II disease 128
Subgroup Analysis According to Human Papillomavirus Status and Tumor Site of a Randomized Phase II Trial Comparing Cetuximab and Cisplatin Combined With Radiation Therapy for Locally Advanced Head and Neck Cancer 124
Clinical outcomes and toxicity after exclusive versus postoperative radiotherapy in supraglottic cancer: new solutions for old problems? The case of stage III and IV disease 122
Oligometastatic prostate cancer patients stratification: A molecular signature identified by liquid biopsy 122
Role of external beam radiotherapy in the treatment of relapsing meningioma 121
Patterns of practice and survival in a retrospective analysis of 1722 adult astrocytoma patients treated between 1985 and 2001 in 12 italian radiation oncology centers 120
Acute skin toxicity management in head and neck cancer patients treated with radiotherapy and chemotherapy or EGFR inhibitors: Literature review and consensus 120
Stereotactic ablative radiation therapy in renal cell carcinoma: From oligometastatic to localized disease. 118
Hypofractionated radiation therapy versus chemotherapy with temozolomide in patients affected by RPA class V and VI glioblastoma: a randomized phase II trial 117
Mebendazole as a candidate for drug repurposing in oncology: An extensive review of current literature 115
Primary cutaneous non-Hodgkin lymphoma: results of a retrospective analysis in the light of the recent ILROG guidelines 114
A benchmark study on 883 nasopharyngeal cancer patients treated in two Italian centres from 1977 to 2000. Part I: evolving technical choices and survival 112
Could Concomitant Radio-Chemotherapy Improve the Outcomes of Early-Stage Node Negative Anal Canal Cancer Patients? A Retrospective Analysis of 122 Patients 112
Whole brain radiotherapy with adjuvant or concomitant boost in brain metastasis: dosimetric comparison between helical and volumetric IMRT technique 112
Radiotherapy for adult medulloblastoma: Long term result from a single institution. A review of prognostic factors and why we do need a multi-institutional cooperative program 111
Circulating tumor cells in patients with recurrent or metastatic head and neck carcinoma: prognostic and predictive significance 111
Cetuximab in the treatment of metastatic mucoepidermoid carcinoma of the salivary glands: a case report and review of literature. 109
Policies for reirradiation of recurrent high-grade gliomas: a survey among Italian radiation oncologists 109
Predictive factors for oropharyngeal mycosis during radiochemotherapy for head and neck carcinoma and consequences on treatment duration. Results of mycosis in radiotherapy (MIR): A prospective longitudinal study 108
Could Machine Learning Improve the Prediction of Pelvic Nodal Status of Prostate Cancer Patients? Preliminary Results of a Pilot Study 107
Oral toxicity management in head and neck cancer patients treated with chemotherapy and radiation: Xerostomia and trismus (Part 2). Literature review and consensus statement 107
Salvage Low Dose Rate Brachytherapy For Recurrent Prostate Cancer After External Beam Radiotherapy: Results From A Single Institution With Focus On Toxicity And Functional Outcomes 107
Supratentorial Gliomas in Eloquent Areas: Which Parameters Can Predict Functional Outcome and Extent of Resection? 107
Association between single nucleotide polymorphisms in the XRCC1 and RAD51 genes and clinical radiosensitivity in head and neck cancer 106
Optimizing Radiation Treatment Decisions for Patients Who Receive Neoadjuvant Chemotherapy 106
Retreatment of recurrent adult medulloblastoma with radiotherapy: a case report and review of the literature. 106
Postoperative radiotherapy for prostate cancer: the sooner the better and potential to reduce toxicity even further 105
Circulating Tumour Cells in locally advanced head and neck cancer: Preliminary report about their possible role in predicting response to non-surgical treatment and survival. 104
Changes in patterns of practice for prostate cancer radiotherapy in Italy 1995-2003. A survey of the Prostate Cancer Study Group of the Italian Radiation Oncology Society 104
Pattern of relapse of glioblastoma multiforme treated with radical radio-chemotherapy: Could a margin reduction be proposed? 104
Radiation Tolerance of Normal Brain: QUANTEC 2010 and Beyond 104
Exploiting Machine Learning for Predicting Nodal Status in Prostate Cancer Patients 103
Dysphagia in head and neck cancer patients treated with radiotherapy and systemic therapies: Literature review and consensus 103
The STYRO 2011 project: a survey on perceived quality of training among young Italian radiation oncologists. 102
Sepsis in head and neck cancer patients treated with chemotherapy and radiation: Literature review and consensus 102
Second line treatment of recurrent glioblastoma with sunitinib: results of a phase II study and systematic review of literature 102
Metastasis-directed stereotactic radiotherapy for oligoprogressive castration-resistant prostate cancer: a multicenter study 102
From Molecular to Clinical Radiation Biology of Glioblastoma 101
Glutamine synthetase expression as a valuable marker of epilepsy and longer survival in newly diagnosed glioblastoma multiforme 101
Open-source, low cost, high-reliability solutions for digital imaging systrems: example of a dicom router/Soluzioni Open Source per sistemi Low Cost e High Reliability per l'imaging digitale: l'esempio di un dicom router. 100
Radiotherapy and Tyrosine Kinase Inhibitors in Stage IV Non-small Cell Lung Cancer: Real-life Experience 98
Analysis of Circulating Tumor Cells in Prostate Cancer Patients at PSA Recurrence and Review of the Literature 98
A benchmark study on 883 nasopharyngeal cancer patients treated in two Italian centres from 1977 to 2000. Part II: evolving technical choices and toxicity patterns 95
Interim PET After Two ABVD Cycles in Early-Stage Hodgkin Lymphoma: Outcomes Following the Continuation of Chemotherapy Plus Radiotherapy 92
Nasopharyngeal carcinoma 91
Information Retrieval in Medicine: an Extensive Experimental Study 91
The growing role of biology in the treatment of glioblastoma: no more one kind of disease 91
Differential Diagnosis and Clinical Management of a Case of COVID-19 in a Patient With Stage III Lung Cancer Treated With Radio-chemotherapy and Durvalumab 91
In haematopoietic SCT for acute leukemia TBI impacts on relapse but not survival: results of a multicentre observational study. 90
Cetuximab and Radiation Therapy in Head and Neck Cancer 90
HER-2 overexpression/amplification in Barrett's oesophagus predicts early transition from dysplasia to adenocarcinoma: a clinico-pathologic study. 89
The impact of the histology of primary tumor on RPA prognostic classifications in patients (pts) treated for brain metastases (BM). Retrospective analysis of 382 pts treated with hypofractionated whole brain radiotherapy (HWBRT). 89
Phase II study of sunitinib and irinotecan in patients with recurrent high-grade glioma (HGG) 89
Radiotherapy in low-grade glioma adult patients: a retrospective survival and neurocognitive toxicity analysis. 89
Exploring the role of enzalutamide in combination with radiation therapy: An in vitro study 89
Radical radiotherapy of bladder cancer retrospective analysis of a series of 459 patients treated in an Italian Institution 88
Reliability of prostate-specific antigen-marker in determining biochemical failure during the first 2 years after external beam radiation therapy and hormone therapy in patients with non-operated prostate cancer. 88
Letter to “Medial lingual lymph node metastasis in carcinoma of the tongue” 88
Interobserver variability in clinical target volume delineation for primary mediastinal B-cell lymphoma 85
Radical radiotherapy for bladder cancer: retrospective analysis of a series of 459 patients treated in an Italian institution. 85
Combination of novel systemic agents and radiotherapy for solid tumors – part I: An AIRO (Italian association of radiotherapy and clinical oncology) overview focused on treatment efficacy 85
Impact of Surgical Approach on Patient-Reported Outcomes after Radical Prostatectomy: A Propensity Score-Weighted Analysis from a Multicenter, Prospective, Observational Study (The Pros-IT CNR Study) 85
Radical radiotherapy for early glottic cancer: Results in a series of 1087 patients from two Italian radiation oncology centers. II. The case of T2N0 disease. 84
Survival and toxicity of radical radiotherapy (with or without brachytherapy) for FIGO stage I and II cervical cancer: a mono-institutional analysis. 83
Localized extranodal lymphoma of the head and neck: retrospective analysis of a series of 107 patients from a single institution. 82
Two months of radiation oncology in the heart of Italian “red zone” during COVID-19 pandemic: paving a safe path over thin ice 82
Practical prognostic score for predicting the extent of resection and neurological outcome of gliomas in the sensorimotor area 82
Post-ABVD/pre-radiotherapy 18F-FDG-PET provides additional prognostic information for early-stage Hodgkin lymphoma: A retrospective analysis on 165 patients 82
A reappraisal of the role of PET and CT/PET in early stage Hodgkin's Disease (HD) in the experience of the florence and Brescia Universities. 81
Three-dimensional conformal radiotherapy, static intensity-modulated and helical intensity-modulated radiotherapy in glioblastoma. Dosimetric comparison in patients with overlap between target volumes and organs at risk. 81
Radiotherapy and temozolomide in anaplastic astrocytoma: a retrospective multicenter study by the Central Nervous System Study Group of AIRO (Italian Association of Radiation Oncology). 80
Re-irradiation for recurrent glioma: outcome evaluation, toxicity and prognostic factors assessment. A multicenter study of the Radiation Oncology Italian Association (AIRO) 78
Radical radiotherapy for early glottic cancer: Results in a series of 1087 patients from two Italian radiation oncology centers. I. The case of T1N0 disease. 77
Stereotactic Radiation Therapy of Lung Cancers and Subsequent Parenchymal Alterations: from Their Spatial Distribution to the Use in Clinical Practice 77
Circulating Tumour Cells in Clinical Practice: Can Lessons Learned From Locally Advanced/Metastatic Breast and Prostate Cancers Guide Their use for other Cancer Types? Lights and Shadows 75
Combination of novel systemic agents and radiotherapy for solid tumors – Part II: An AIRO (Italian association of radiotherapy and clinical oncology) overview focused on treatment toxicity 75
Mucositis in head and neck cancer patients treated with radiotherapy and systemic therapies: Literature review and consensus statements 75
Short fractionation radiotherapy for early prostate cancer in the time of COVID-19: long-term excellent outcomes from a multicenter Italian trial suggest a larger adoption in clinical practice 74
Hypofractionated radiotherapy with simultaneous integrated boost (SIB) plus temozolomide in good prognosis patients with glioblastoma: a multicenter phase II study by the Brain Study Group of the Italian Association of Radiation Oncology (AIRO) 73
Radiosurgery and fractionated stereotactic radiotherapy in oligometastatic/oligoprogressive non-small cell lung cancer patients: Results of a multi-institutional series of 198 patients treated with “curative” intent 73
Totale 10.847
Categoria #
all - tutte 60.524
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 60.524


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019953 0 0 0 0 0 0 0 0 31 199 393 330
2019/20203.943 475 135 142 414 235 510 417 442 305 499 139 230
2020/20212.932 79 282 136 327 151 357 113 316 320 394 262 195
2021/20221.355 110 197 38 58 16 75 54 113 75 161 86 372
2022/20231.392 188 88 47 103 126 339 8 142 217 22 65 47
2023/20241.428 90 35 196 99 101 413 64 80 350 0 0 0
Totale 14.406